You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 241 No. 5, February 2, 1979 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

On the diagnosis and treatment of breast cancer

M. S. Fox

Randomized trials comparing surgical treatments of breast cancer show that radical mastectomy offers no greater benefit than simple mastectomy followed by radiotherapy. Furthermore, in terms of survival, radical mastectomy seems to be no better than wide excision followed by radiotherapy when the disease is clinically diagnosed as stage 1. The incidence of diagnosed breast cancer showed an 18% increase between 1935 and 1965 and a 50% increase between 1965 and 1975. However, breast cancer mortality has remained unchanged for at least the past 40 years. Analysis of survival curves of women with breast cancer suggests that two or more populations exist, with about 40% suffering fatal outcome unaffected by treatment. The remaining 60% exhibit a relative mortality only modestly different from that of women of similar ages without evidence of disease. Increasing detection of an entity that is histologically defined as malignant but biologically relatively benign could account for the observed increase in incidence.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Age-Related Crossover in Breast Cancer Incidence Rates Between Black and White Ethnic Groups
Anderson et al.
JNCI J Natl Cancer Inst 2008;100:1804-1814.
ABSTRACT | FULL TEXT  

Shifting Breast Cancer Trends in the United States
Anderson et al.
JCO 2007;25:3923-3929.
ABSTRACT | FULL TEXT  

Breast cancer heterogeneity: a mixture of at least two main types?
Anderson and Matsuno
JNCI J Natl Cancer Inst 2006;98:948-951.
FULL TEXT  

Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen
Widschwendter et al.
Cancer Res. 2004;64:3807-3813.
ABSTRACT | FULL TEXT  

On the benefits and harms of screening for breast cancer
Gotzsche
Int J Epidemiol 2004;33:56-64.
FULL TEXT  

Repeated observation of breast tumor subtypes in independent gene expression data sets
Sorlie et al.
Proc. Natl. Acad. Sci. USA 2003;100:8418-8423.
ABSTRACT | FULL TEXT  

Tumor Variants by Hormone Receptor Expression in White Patients With Node-Negative Breast Cancer From the Surveillance, Epidemiology, and End Results Database
Anderson et al.
JCO 2001;19:18-27.
ABSTRACT | FULL TEXT  

Clinical Progression of Breast Cancer Malignant Behavior: What to Expect and When to Expect it
Heimann and Hellman
JCO 2000;18:591-591.
ABSTRACT | FULL TEXT  

Basic Principles in Surgical Oncology
Cady
Arch Surg 1997;132:338-346.
ABSTRACT  

Not All Nonpalpable Breast Cancers Are Alike
Franceschi et al.
Arch Surg 1991;126:967-971.
ABSTRACT  

An Overview and Critical Analysis of Breast Cancer Screening
Lung et al.
Arch Surg 1988;123:833-838.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.